| Literature DB >> 34159147 |
Herlina Herlina1, Annisa Amriani1, Indah Permata Sari1, Elsa Fitria Apriani1.
Abstract
In this study, acute toxicity of kenikir leaf (Cosmos caudatus HBK) ethanolic extract was conducted on Wistar white male rats with fixed dose procedure. The extraction method used was maceration using 70% ethanol. A dose of 2000 mg/kgBW was determined as the starting dose based on the preliminary test result. The rats used in the main test were divided into the normal group and the 2000 mg/kgBW dose group, each used five animals in each group. The results of the test showed that there were no deaths or toxic symptoms both of the normal group and the 2000 mg/kgBW dose group. The conducted preliminary test results a dose of 2000 mg/kgBW as the starting dose. Next, main test is done toward two groups of rats: Normal group and 2000 mg/kgBW dose group each consist of five animals. The main test results in neither deaths nor toxic symptoms from those groups. The range of toxic doses of kenikir leaf ethanolic extract that can cause acute toxicity is >2000 mg/kgBW, and hence, this experiment classified in the practically nontoxic category. Statistical analysis on effect to macroscopic organs of the liver, heart, and kidney showed no significance (P > 0.05) from kenikir leaf ethanolic extract. Average levels of biochemical parameters from the 2000 mg/kgBW group and the normal group were in the normal range. Ethanolic extract at a dose of 333 mg/kg BW does not cause severe pancreatic damage, and hence, it is considered safe for use as an antidiabetic. Copyright:Entities:
Keywords: Acute toxicity; Cosmos caudatus HBK; fixed dose procedure; kenikir leaf
Year: 2021 PMID: 34159147 PMCID: PMC8177147 DOI: 10.4103/japtr.JAPTR_90_20
Source DB: PubMed Journal: J Adv Pharm Technol Res ISSN: 0976-2094
Phytochemical screening results of kenikir leaf ethanolic extract
| Secondary metabolites | Results |
|---|---|
| Flavonoids | + |
| Alkaloids | − |
| Saponin | + |
| Tannin | + |
| Phenolic | + |
| Steroids | + |
| Triterpenoid | − |
+: Positive, −: Negative
Results of preliminary test observations
| Group | Treatment | Number of mice | Number of dead mice | Symptoms of toxicity | |||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | ||||
| Normal | Distilled water | 1 | 0 | − | − | − | − | − | − |
| Test 1 | Dose of 5 mg/kgBW | 1 | 0 | − | − | − | − | − | − |
| Test 2 | Dose of 50 mg/kgBW | 1 | 0 | − | − | − | − | − | − |
| Test 3 | Dose 300 mg/kgBW | 1 | 0 | − | − | − | − | − | − |
| Test 4 | Dose 2000 mg/kgBW | 1 | 0 | − | − | − | − | − | − |
1: Walk backwards, 2: Walk with stomach, 3: Tremors, 4: Diarrhea, 5: Salivation, 6: Limp, −: There are no symptoms, +: There are had symptoms, BW: Body weight
Main test observations
| Group | Treatment | Number of mice | Number of dead mice | Symptoms of toxicity | |||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | ||||
| Normal | Distilled water | 5 | 0 | − | − | − | − | − | − |
| Test | Dose 2000 mg/kgBW | 5 | 0 | − | − | − | − | − | − |
1: Walk backwards, 2: Walk with stomach, 3: Tremors, 4: Diarrhea, 5: Salivation, 6: Limp, −: There are no symptoms +: There are had symptoms, BW: Body weight
Figure 1Histopathological picture of Langerhans Island with a magnification of 100 times. (a) Normal group; (b) Group dosage 333 mg/kg body weight; (c) Group dosage of 2000 mg/kg
Levels of serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, creatinine, and urea of test animals
| Group | Biochemical parameters | |||
|---|---|---|---|---|
| SGOT (U/L) | SGPT (U/L) | Creatinine (mg/dL) | Ureum (mg/dL) | |
| Normal (average) | 65.020±12.207 | 67.094±3.737 | 0.706±0.336 | 14.60±0.684 |
| 2000 mg/kgBW dose (average) | 71.216±9.649 | 85.218±8.314 | 0.958±0.167 | 18.760±2.744 |
SGOT: Serum glutamic oxaloacetic transaminase, SGPT: Serum glutamic pyruvic transaminase, BW: Body weight